BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 25287582)

  • 21. Radiotherapy for pleomorphic adenoma of the parotid gland.
    Barton J; Slevin NJ; Gleave EN
    Int J Radiat Oncol Biol Phys; 1992; 22(5):925-8. PubMed ID: 1313407
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Follow-up of parotid pleomorphic adenomas treated by extracapsular dissection.
    Iro H; Zenk J; Koch M; Klintworth N
    Head Neck; 2013 Jun; 35(6):788-93. PubMed ID: 22581729
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Recurrences of pleomorphic adenomas of the parotid: changing attitudes].
    Paris J; Facon F; Chrestian MA; Giovanni A; Zanaret M
    Rev Laryngol Otol Rhinol (Bord); 2003; 124(4):229-34. PubMed ID: 15038565
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cerebral radionecrosis following the treatment of parotid tumours: a case report and review of the literature.
    Coghlan KM; Magennis P
    Int J Oral Maxillofac Surg; 1999 Feb; 28(1):50-2. PubMed ID: 10065650
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Radiotherapy of salivary gland neoplasms].
    Stauch GW; Makoski HB; Fiebach O
    Strahlentherapie; 1972 Sep; 144(3):253-66. PubMed ID: 4343597
    [No Abstract]   [Full Text] [Related]  

  • 26. Superfacial parotidectomy for pleomorphic parotid adenomas.
    Hawe MJ; Bell DM
    Clin Oncol; 1982; 8(3):207-13. PubMed ID: 7140047
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic factors for secondary recurrence of pleomorphic adenoma: a 20-year, retrospective study.
    Malard O; Wagner R; Joubert M; Delemazure AS; Rio E; Durand N; Espitalier F
    J Laryngol Otol; 2013 Sep; 127(9):902-7. PubMed ID: 23962377
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Recurrence tendency and malignant transformation of pleomorphic adenomas].
    Chilla R; Schneider K; Droese M
    HNO; 1986 Nov; 34(11):467-9. PubMed ID: 3027008
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of postoperative radiation therapy in carcinoma ex pleomorphic adenoma of the parotid gland.
    Chen AM; Garcia J; Bucci MK; Quivey JM; Eisele DW
    Int J Radiat Oncol Biol Phys; 2007 Jan; 67(1):138-43. PubMed ID: 17049183
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Long-term results of treatment of the so-called mixed tumors of the parotid salivary gland (according to the records of the P. A. Herzen State Oncological Institute for 1945-1962)].
    Kiseleva ES; Dar'ialova SL
    Vopr Onkol; 1965; 11(10):100-5. PubMed ID: 4289105
    [No Abstract]   [Full Text] [Related]  

  • 31. Recurrent pleomorphic adenoma of the parotid gland.
    Leonetti JP; Marzo SJ; Petruzzelli GJ; Herr B
    Otolaryngol Head Neck Surg; 2005 Sep; 133(3):319-22. PubMed ID: 16143173
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The surgical management of recurrent or residual pleomorphic adenomas of the parotid gland. Analysis and results in 40 patients.
    Leverstein H; Tiwari RM; Snow GB; van der Wal JE; van der Waal I
    Eur Arch Otorhinolaryngol; 1997; 254(7):313-7. PubMed ID: 9298665
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Post-irradiation carcinosarcoma of the parotid gland.
    Spraggs PD; Rose DS; Grant HR; Gallimore AP
    J Laryngol Otol; 1994 May; 108(5):443-5. PubMed ID: 8035132
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recurrent pleomorphic adenoma of the parotid gland in pediatric and adult patients: value of multiple lesions as a diagnostic indicator.
    Koral K; Sayre J; Bhuta S; Abemayor E; Lufkin R
    AJR Am J Roentgenol; 2003 Apr; 180(4):1171-4. PubMed ID: 12646477
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preservation of the facial nerve in the management of recurrent pleomorphic adenoma.
    Samson MJ; Metson R; Wang CC; Montgomery WW
    Laryngoscope; 1991 Oct; 101(10):1060-2. PubMed ID: 1656154
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Pleomorphic parotid adenomas and their recurrence].
    Federspil PA; Federspil P; Schätzle W
    HNO; 1994 Jan; 42(1):28-35. PubMed ID: 8150670
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Retrospective appreciation of results of treatment and early and late radiologic mucositis and other postradiological complications in patients with parotid gland cancer irradiated postoperatively].
    Laskus Z; Kawecki A
    Otolaryngol Pol; 2004; 58(2):297-304. PubMed ID: 15307475
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neutron radiotherapy for recurrent pleomorphic adenomas of major salivary glands.
    Douglas JG; Einck J; Austin-Seymour M; Koh WJ; Laramore GE
    Head Neck; 2001 Dec; 23(12):1037-42. PubMed ID: 11774388
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The recurrent multifocal pleomorphic adenoma].
    Vigili MG; Sciarretta F; Marzetti A; Marzetti F
    Acta Otorhinolaryngol Ital; 1993; 13(1):31-42. PubMed ID: 8135096
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Surgical treatment of benign tumours of the salivary glands.
    Van Hee R; Misset M; Ysebaert D; Van de Heyning P; Koekelkoren E; Claes L; Van Laer C; Peeters L; Hintjens J; Van Elst F; Van Marck E; Bultinck J
    Acta Chir Belg; 1996; 96(4):161-4. PubMed ID: 8830872
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.